Kiromic BioPharma (KRBP, $2.02) was a top loser over the last three months, falling -2 to $2.02 per share. A.I.dvisor analyzed 862 stocks in the Biotechnology Industry for the 3-month period ending September 12, 2024, and found that of them () exhibited an Uptrend while of them () demonstrated a Downtrend.